Skip to main content
Clinical Trials/NCT06726915
NCT06726915
Not yet recruiting
Not Applicable

Effect of Different Maternal Hemoglobin and Hematocrit Values on Perinatal Outcome

Ali Mohamed Mohamed Ammar0 sites403 target enrollmentJanuary 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemoglobin and Hematocrit Values on Perinatal Outcome
Sponsor
Ali Mohamed Mohamed Ammar
Enrollment
403
Primary Endpoint
Fetal weight measurement- still birth or major morbidity
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to evaluate the perinatal outcome in pregnancies with different levels of hemoglobin/hematocrit to verify which category of women should have iron supplementation if not all.

Detailed Description

Anaemia in pregnant women has been reported to have various adverse effects on both the mother and unborn foetus. These effects include preterm birth, a low birth weight and an increase in the risk of maternal and perinatal mortality . Postpartum anaemia impairs wound healing, increases the risk for readmission and/or prolonged hospitalization, and increases the cost of care for families . Some investigators stated adverse perinatal outcome in pregnant mothers with high haemoglobin and haematocrit values and raised a question about the possible harmful effect of iron supplementation in such pregnancies.

Registry
clinicaltrials.gov
Start Date
January 2025
End Date
May 2026
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
Ali Mohamed Mohamed Ammar
Responsible Party
Sponsor Investigator
Principal Investigator

Ali Mohamed Mohamed Ammar

Doctor

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Pregnant women scheduled for labor or C.S (at term, 28-42 weeks).
  • Singleton pregnancy.
  • Age range: 18-40 years.
  • Willing to provide informed consent for participation and follow-up.

Exclusion Criteria

  • Refusal to participate or consent.
  • Presence of non-iron deficiency anemia (e.g., hemoglobinopathies, chronic disease-related anemia).
  • Multiple pregnancies (e.g., twins or more).
  • Antepartum hemorrhage (e.g., placenta previa, placental abruption).
  • Malformed fetus. -

Outcomes

Primary Outcomes

Fetal weight measurement- still birth or major morbidity

Time Frame: Baseline

Secondary Outcomes

  • Maternal needs for iron therapy(Baseline)
  • . Un-even postpartum period: Failure of lactation- DVT- CS wound complications Postpartum anaemia(Baseline)

Similar Trials